The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Medical technology, the pharmaceutical industry and biotechnology are sectors in which sensors and measurement technology are increasingly being used to improve quality and efficiency. Micro-Epsilon ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy Sokolove, M.D., as Chief Medical Officer. Dr.

ProQR ( ($PRQR) ) has issued an announcement. On November 3, 2025, ProQR Therapeutics hosted a virtual analyst and investor event to discuss its ...

These healthcare stocks are making strides in very important ways. The healthcare industry revolves around constant innovation in areas like biotechnology, pharmaceuticals, medical devices, and ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, today announced that it has ...

Tharimmune, Inc., a clinical-stage biotechnology company traditionally focused on developing therapies for rare immune, ...

LONDON and MILAN, Nov. 03, 2025(AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 milli ...

Life Bio adds accomplished biotech leader to its Board as the company prepares for an early 2026 initiation of human trials ...